Korean Dementia Association: “Leqembi's Side Effects Are Not Significant”
The Korean Dementia Association has addressed safety concerns related to the upcoming domestic release of the Alzheimer’s treatment Leqembi (ingredient: lecanemab), stating that the side effects are not significant enough…